Request Deal Involvement
Liminatus Pharma went public via a SPAC merger with Arrow Capital-backed Iris Acquisition in a $334m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Trequartista Consulting
financial advisors
Raymond James
or
Principals
bidder
IRIS ACQUISITION CORP
bidder
ARROW CAPITAL PARTNERS
target
LIMINATUS PHARMA
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite